ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

QLGN Qualigen Therapeutics Inc

4.01
-0.03 (-0.74%)
24 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.39M1.61M1.63M00000
Operating Income -8.65M-3.69M-3.55M-1.15M-2.27M-1.42M-1.75M-1.26M
Pre Tax Income -8.8M-4.27M-3.55M-2.19M-2.47M-2.03M-1.48M-1.79M
Net Income -5.9M-3.85M-3.46M-3.66M-2.45M-2.03M-1.58M-1.88M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.65M-4.77M-3.61M-1.09M-2.27M-1.42M-1.87M-937k
EBITDA -4.35M-3.63M-3.56M-1.2M-2.27M-1.42M-1.75M-1.26M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00002.85M5.65M4.98M0
Operating Income -18.45M-7.9M-17M-10.84M-11.9M-22.66M-22.18M-11.31M
Pre Tax Income -18.39M-7.86M-16.87M-10.13M-19.55M-17.89M-21.3M-12.48M
Net Income -18.39M-10.98M-19.41M-10.13M-19.55M-17.9M-18.64M-13.42M
Preferred Dividends 0-3.11M-2.54M00000
Basic Earnings Per Share (EPS) -1.582-0.222-3.215-0.53-0.716-0.507-0.443-2.59
EBIT -18.45M-7.9M-17M-10.26M-11.19M-22.66M-22.18M-12.37M
EBITDA -18.44M-7.9M-16.99M-10.84M-10.43M-22.55M-17.79M-11.3M

Your Recent History

Delayed Upgrade Clock